Based on receptor type, BC was categorized into four groups: HER2+, ER-(progesterone receptor) PR-HER2-, A/B (ER and/or progesterone receptor PR positive and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.